Explore
Validate
Learn
Western blot
Immunocytochemistry
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN2846746 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Retinoic Acid Receptor, alpha (RARA) (AA 322-349), (C-Term) antibody
- Antibody type
- Polyclonal
- Description
- This antibody is purified through a protein A column, followed by peptide affinity purification.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Epitope
- AA 322-349, C-Term
- Antibody clone number
- RB33783
- Vial size
- 80 μL
- Storage
- RARA Antibody (C-term) can be refrigerated at 2-8°C for up to 6 months. For long term storage, place the at -20°C.
Submitted references A novel cytoplasmic adaptor for retinoic acid receptor (RAR) and thyroid receptor functions as a Derepressor of RAR in the absence of retinoic acid.
Amplification of the RARA gene in acute myeloid leukemia: significant finding or coincidental observation?
The PRKAR1A gene is fused to RARA in a new variant acute promyelocytic leukemia.
PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors.
Park UH, Kim EJ, Um SJ
The Journal of biological chemistry 2010 Oct 29;285(44):34269-78
The Journal of biological chemistry 2010 Oct 29;285(44):34269-78
Amplification of the RARA gene in acute myeloid leukemia: significant finding or coincidental observation?
Asleson AD, Morgan V, Smith S, Velagaleti GV
Cancer genetics and cytogenetics 2010 Oct 1;202(1):33-7
Cancer genetics and cytogenetics 2010 Oct 1;202(1):33-7
The PRKAR1A gene is fused to RARA in a new variant acute promyelocytic leukemia.
Catalano A, Dawson MA, Somana K, Opat S, Schwarer A, Campbell LJ, Iland H
Blood 2007 Dec 1;110(12):4073-6
Blood 2007 Dec 1;110(12):4073-6
PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors.
Chen Z, Guidez F, Rousselot P, Agadir A, Chen SJ, Wang ZY, Degos L, Zelent A, Waxman S, Chomienne C
Proceedings of the National Academy of Sciences of the United States of America 1994 Feb 1;91(3):1178-82
Proceedings of the National Academy of Sciences of the United States of America 1994 Feb 1;91(3):1178-82
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
